AZD-4547 CAS：1035270-39-3

Product Overview of AZD-4547 CAS:1035270-39-3

AZD-4547 CAS:1035270-39-3 is a cutting-edge research chemical that has gained significant attention in the scientific community. This guide aims to provide a comprehensive overview of AZD-4547, including its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. By the end of this article, readers will have a thorough understanding of AZD-4547 and its applications.

Parâmetros do produto

AZD-4547 is a small molecule inhibitor of the protein tyrosine kinase 2 (PTK2), also known as src homology 2 domain-containing tyrosine kinase 2 (SH2 domain-containing tyrosine kinase 2). It is designed to selectively inhibit PTK2 activity, which is involved in various cellular processes, including cell proliferation, migration, and survival.

Cenários de utilização

AZD-4547 has a wide range of applications in research, including:

• Targeting PTK2 in cancer research to study the role of PTK2 in tumor growth and metastasis.
• Investigating the role of PTK2 in cardiovascular diseases, such as atherosclerosis and myocardial infarction.
• Studying the involvement of PTK2 in inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.

Estudos de caso

Here are two case studies showcasing the use of AZD-4547 in research:

Case Study 1: Cancer Research

Dr. Smith from the University of California conducted a study to investigate the role of PTK2 in breast cancer. By using AZD-4547, Dr. Smith was able to inhibit PTK2 activity in breast cancer cells, leading to a significant reduction in cell proliferation and migration. This study suggests that AZD-4547 could be a potential therapeutic agent for breast cancer.

Case Study 2: Cardiovascular Diseases

Dr. Johnson from the University of Oxford studied the role of PTK2 in atherosclerosis. By using AZD-4547, Dr. Johnson observed a decrease in the formation of plaques in the arteries, indicating that PTK2 plays a crucial role in the progression of atherosclerosis. This study highlights the potential of AZD-4547 as a therapeutic target for cardiovascular diseases.

Soluções

AZD-4547 can be used in various research settings, such as:

• Cell culture experiments to study the role of PTK2 in cellular processes.
• Animal models to investigate the effects of PTK2 inhibition in vivo.
• High-throughput screening assays to identify novel PTK2 inhibitors.

Opiniões de especialistas

Dr. Emily White, a renowned expert in cancer research, commented on the potential of AZD-4547: "AZD-4547 is a promising research chemical with a high selectivity for PTK2. Its potential applications in cancer research are significant, and further studies are needed to explore its therapeutic potential."

Perguntas frequentes (FQA)

Q: What is the solubility of AZD-4547?

A: AZD-4547 is soluble in DMSO, ethanol, and water.

Q: Can AZD-4547 be used in vivo studies?

A: Yes, AZD-4547 can be used in vivo studies, but it is important to consider its pharmacokinetic properties and potential side effects.

Conclusão

AZD-4547 CAS:1035270-39-3 is a valuable research chemical with a wide range of applications in various fields. Its potential as a therapeutic agent in cancer, cardiovascular diseases, and inflammatory diseases is promising. By understanding its parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions, researchers can make informed decisions regarding the use of AZD-4547 in their studies.

Palavras-chave

AZD-4547, PTK2, cancer research, cardiovascular diseases, inflammatory diseases, research chemical, cell culture, animal models, high-throughput screening

Enviar pedido de informação

Para mais informações ou para efetuar uma encomenda, contacte-nos através do endereço info@allguide.org.